AKT1 and Alzheimer disease: Downstream insulin signaling pathways which are altered in AD involve increased expression of mitogen-activated protein kinase (MAPK), disturbed signaling of protein kinase B (Akt), and activation of glycogen synthase kinase 3β (GSK-3β) which hyperphosphorylates tau [107].